 REDWOOD CITY, Calif.--BUSINESS WIRE--Guardant Health, Inc. Nasdaq: GH, along with leading academic institutions and pharmaceutical companies, presents new data at the AACR Virtual Annual Meeting I, April 10-15, 2021, highlighting the use of the companys proprietary blood tests to advance precision oncology. Key findings demonstrate the value of Guardant360, Guardant360 CDx, and GuardantOMNITM liquid biopsy tests to detect clinically actionable mutations, inform treatment for patients as th 